PAD and Claudication
Conference Coverage
New ESC guidelines for cutting CV risk in noncardiac surgery
The guidelines, which aim to reduce cardiovascular complications from noncardiac surgery, introduce new concepts and recommendations, compared...
From the Journals
Add AFib to noncardiac surgery risk evaluation: New support
Preexisting atrial fibrillation should again be part of pre–noncardiac surgery cardiac risk assessment, argues a new report.
News from the FDA/CDC
FDA update: Higher late mortality with paclitaxel-coated devices
From the Journals
New vascular 0 + 5 training programs yield fewer PAD cases
From the Journals
Ask patients, not devices, about impact of PAD
News from the FDA/CDC
FDA: Benefits still outweigh risks from paclitaxel-coated devices for PAD
The FDA is investigating data from a recent meta-analysis of increased long-term mortality risk from paclitaxel-coated balloons and paclitaxel-...
Conference Coverage
Drug-coated balloon advantage persists in femoral artery disease
The 5-year results from IN.PACT are consistent with those previously reported at 1, 2, and 3 years.
From the Journals
Frailty tied to higher mortality after major vascular surgery
From the Journals
Claudication, CLI differ significantly in hospital readmission, costs, mortality
From the Journals
Tracking 90-day vascular surgery outcomes: The coming new normal?
From the Journals
Fewer groin infections with closed incision negative pressure therapy after vascular surgery